Clinical trial
Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)
NCT00387036 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00387036 |
|---|---|
| Title | Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036) |
| Official title | A Multicenter, Double-Blind Placebo-Controlled Crossover Study to Investigate the Effects of an Inhaled Corticosteroid on Cardiopulmonary Exercise Parameters in Patients With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Drug |
| Interventions | Fluticasone, Comparator: Placebo |
| Enrollment | 12 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Oct 12, 2006 |
| Last update posted | Jan 21, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: